Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 18 U.S. jurisdictions and the EU. Columbia Care operates 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities, including those under development. Columbia Care is one of the original multi-state providers of medical cannabis in the U.S. and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber and Platinum Label CBD.

Quarterly Results

Show all



Quarter Ended Jun 30, 2022

Press Releases

15 Aug '22
Quarterly Revenue of $129.6 Million , an Increase of 5% QoQ and 18% YoY Gross Profit of $50.8 Million , an Increase of 17% YoY Adjusted EBITDA 1 of $12.0 Million and YTD Adjusted EBITDA Margin 1 of 11% Expected to Be Last Quarterly Results before Announcing Divestitures Related to Combination with